165 related articles for article (PubMed ID: 37746186)
1. Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis.
Román-Montes CM; Bojorges-Aguilar S; Díaz-Lomelí P; Cervantes-Sánchez A; Rangel-Cordero A; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-León A; González-Lara MF
Front Fungal Biol; 2022; 3():855914. PubMed ID: 37746186
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
[TBL] [Abstract][Full Text] [Related]
4. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
[TBL] [Abstract][Full Text] [Related]
7. Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate.
van Grootveld R; van Paassen J; de Boer MGJ; Claas ECJ; Kuijper EJ; van der Beek MT;
Mycoses; 2021 Jun; 64(6):641-650. PubMed ID: 33606324
[TBL] [Abstract][Full Text] [Related]
8. "CAPA in Progress": A New Real-Life Approach for the Management of Critically Ill COVID-19 Patients.
Carbonell N; Alcaráz MJ; Serrano-Lázaro A; Rodríguez-Gimillo M; Sánchez Ramos D; Ros F; Ferrer J; Blasco ML; Navarro D; Clari MÁ
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884988
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
[TBL] [Abstract][Full Text] [Related]
11. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
[TBL] [Abstract][Full Text] [Related]
13. Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture.
Pavone P; Russello G; Salati G; Corsini R; Salsi P; Vizzini L; Lombardini C; Spaggiari L; Besutti G; Menozzi V; Spadoni A; Facciolongo N; Piro R; Carretto E; Massari M
Mycoses; 2023 Mar; 66(3):219-225. PubMed ID: 36380646
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.
Paramythiotou E; Dimopoulos G; Koliakos N; Siopi M; Vourli S; Pournaras S; Meletiadis J
Infect Dis Ther; 2021 Sep; 10(3):1779-1792. PubMed ID: 34260038
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
Lackner N; Thomé C; Öfner D; Joannidis M; Mayerhöfer T; Arora R; Samardzic E; Posch W; Breitkopf R; Lass-Flörl C
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205848
[TBL] [Abstract][Full Text] [Related]
18. Performance of galactomannan testing from endotracheal aspirate to guide bronchoalveolar lavage in the diagnosis of invasive aspergillosis.
Dichtl K; Barry R; Angstwurm MWA; Suerbaum S; Wagener J
Infection; 2023 Jun; 51(3):769-774. PubMed ID: 36738420
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
[TBL] [Abstract][Full Text] [Related]
20. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
